DE69433057D1 - Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus - Google Patents
Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virusInfo
- Publication number
- DE69433057D1 DE69433057D1 DE69433057T DE69433057T DE69433057D1 DE 69433057 D1 DE69433057 D1 DE 69433057D1 DE 69433057 T DE69433057 T DE 69433057T DE 69433057 T DE69433057 T DE 69433057T DE 69433057 D1 DE69433057 D1 DE 69433057D1
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- vaccinating
- antibodies against
- neutralizing antibodies
- human immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4897693A | 1993-04-16 | 1993-04-16 | |
| US48976 | 1993-04-16 | ||
| PCT/SE1994/000340 WO1994023746A1 (en) | 1993-04-16 | 1994-04-15 | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69433057D1 true DE69433057D1 (de) | 2003-09-25 |
| DE69433057T2 DE69433057T2 (de) | 2004-06-03 |
Family
ID=21957441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69433057T Expired - Fee Related DE69433057T2 (de) | 1993-04-16 | 1994-04-15 | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0693938B1 (de) |
| JP (1) | JPH09500096A (de) |
| AT (1) | ATE247485T1 (de) |
| AU (2) | AU6515394A (de) |
| CA (1) | CA2160696C (de) |
| DE (1) | DE69433057T2 (de) |
| ES (1) | ES2202321T3 (de) |
| WO (1) | WO1994023746A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2313376A (en) * | 1996-05-22 | 1997-11-26 | Diapharm Limited | Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP) |
| AU4251197A (en) * | 1996-09-06 | 1998-03-26 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Therapeutic chemokine antagonists |
| CA2398816A1 (en) | 2000-02-04 | 2001-08-09 | Duke University | Human immunodeficiency virus vaccine |
| WO2005097822A1 (en) * | 2004-04-09 | 2005-10-20 | University Of Manitoba | Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12 |
| CN112745382B (zh) * | 2021-01-22 | 2022-05-31 | 浙江辉肽生命健康科技有限公司 | 具有氨基酸结构ltvinqtqkenlr的生物活性肽及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2194836T3 (es) * | 1990-09-27 | 2003-12-01 | Tripep Ab | Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana. |
| JPH06510025A (ja) * | 1991-06-03 | 1994-11-10 | シンテロ ヴァクシン デベロップメント アクチ ボラゲット | Ｈｉｖ−１に対するｔ細胞活性化の誘導に用いられるペプチド |
-
1994
- 1994-04-15 AT AT94912727T patent/ATE247485T1/de not_active IP Right Cessation
- 1994-04-15 DE DE69433057T patent/DE69433057T2/de not_active Expired - Fee Related
- 1994-04-15 ES ES94912727T patent/ES2202321T3/es not_active Expired - Lifetime
- 1994-04-15 CA CA002160696A patent/CA2160696C/en not_active Expired - Fee Related
- 1994-04-15 WO PCT/SE1994/000340 patent/WO1994023746A1/en active IP Right Grant
- 1994-04-15 JP JP6523055A patent/JPH09500096A/ja active Pending
- 1994-04-15 EP EP94912727A patent/EP0693938B1/de not_active Expired - Lifetime
- 1994-04-15 AU AU65153/94A patent/AU6515394A/en not_active Abandoned
-
1997
- 1997-12-11 AU AU48320/97A patent/AU4832097A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0693938A1 (de) | 1996-01-31 |
| WO1994023746A1 (en) | 1994-10-27 |
| DE69433057T2 (de) | 2004-06-03 |
| JPH09500096A (ja) | 1997-01-07 |
| AU4832097A (en) | 1998-03-12 |
| EP0693938B1 (de) | 2003-08-20 |
| AU6515394A (en) | 1994-11-08 |
| ES2202321T3 (es) | 2004-04-01 |
| CA2160696C (en) | 2004-08-03 |
| CA2160696A1 (en) | 1994-10-27 |
| ATE247485T1 (de) | 2003-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE144143T1 (de) | Künstlicher impfstoff gegen aids-virus | |
| MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
| DE68924162D1 (de) | Stressproteine und verwendungen dafür. | |
| DE69327587D1 (de) | Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend | |
| MA24638A1 (fr) | Vaccin | |
| ES2307496T4 (es) | Composiciones de vacuna, antígenos y péptidos de VIH | |
| GB2255093A (en) | Hiv-1 core protein fragments | |
| DK1278534T3 (da) | Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1 | |
| NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
| ATE238065T1 (de) | Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus | |
| DE69433007D1 (de) | Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus | |
| ATE134195T1 (de) | Peptidfragmente von hiv | |
| DE69327529D1 (de) | Immunologisch mit HLA homologe HIV Protein Epitope | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| ES2143996T3 (es) | Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv. | |
| WO2004005316A3 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes | |
| WO2002045743A3 (en) | Hcv vaccines | |
| HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
| DE69233271D1 (de) | Therapeutischer- und präventivimpfstoff gegen hiv | |
| SE9600436D0 (sv) | Vaccine against hantavirus | |
| Isola | Studies on the antigenic structure of herpes simplex virus glycoprotein D. | |
| DE60216958D1 (de) | Eine den gp41-zwischenzustand imitierende struktur bildendes polypeptid-antigen | |
| DE68922540D1 (de) | Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |